Stock Trading Family Diary, Live Trading Journal — Day 20 (with Portfolio) Part 1

StrawberryIce · 2026-02-10T03:30:42+00:00

The author documented their stock market trades with the goal of turning 700,000 yuan of principal into 7 million within a year. Currently, they have achieved 1.48 million. They shared detailed trading records and profit situations, emphasizing the importance of real trading operations and warning about stock market risks.

StrawberryIce

2026-02-10 03:30:42

Abstract generation in progress

Stock Trading to Support the Family! Year-End Battle! [Taogu Ba]

Principal: 700,000 yuan, goal: 10x in one year to reach 7 million. Today is the 20th day, currently at 1.48 million, let’s witness together.

I will record every day’s operations with a real account, demonstrating the path to doubling through action!

I believe that real trading is the best proof. As long as we stay steady and persistent, we will surely advance vigorously all the way!

This is only the 20th day since I arrived at Taoxian, I hope all fellow investors support me, like for a lifetime of wealth, comment 178, and let’s grow together!

Special statement: This content is a personal real trading record, not investment advice, and I do not encourage copying trades! The stock market has risks; please invest rationally.

Current holdings: none

Morning entry: Jiecheng Shares, Guofeng New Materials

Profit-taking exit in the morning: Tuori New Energy, Litong Electronics, Saiwu Technology

Alright, I’m showing off now:

Hengdian’s position from the day I bought in until today has gained 25cm of meat.

Tefax Information was mentioned to everyone as early as February 6, and I reiterated it yesterday; it opened with a direct limit-up.

And today’s morning talk about Jiecheng Shares, I caught another opportunity. There was a chance to buy in the morning.

Is Longshen Niu really that awesome? Listen to me these days, you’ll have a good year at home! No operations are expected this afternoon; check the comments section of this post for details.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.